Margo R Roberts Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Margo R Roberts.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Margo R Roberts. Margo R Roberts is Director in Unity Biotechnology, Inc. ($UBX) and Chief Scientific Officer in Kite Pharma, Inc. ($KITE).
Latest Insider Trading Transactions of Margo R Roberts
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2020 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
Jun 24 2019 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
Dec 04 2018 | UBX | Unity Biotechnolog ... | Roberts Margo R | Director | Option Exercise | A | 13.67 | 50,661 | 692,536 | 50,661 | |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 1,006 | 17,102 | 30,575 | |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 7,500 | 5,250 | 56,250 | |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 47.78 | 255 | 12,184 | 10,655 | 10.9 K to 10.7 K (-2.34 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 46.34 | 436 | 20,204 | 10,910 | 11.3 K to 10.9 K (-3.84 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 45.09 | 7,815 | 352,378 | 11,346 | 19.2 K to 11.3 K (-40.79 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 1,006 | 17,102 | 19,161 | 18.2 K to 19.2 K (+5.54 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 7,500 | 5,250 | 18,155 | 10.7 K to 18.2 K (+70.39 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 9,632 | 6,742 | 62,743 | |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 46.01 | 100 | 4,601 | 9,098 | 9.2 K to 9.1 K (-1.09 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 45.05 | 9,532 | 429,417 | 9,198 | 18.7 K to 9.2 K (-50.89 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 9,632 | 6,742 | 18,730 | 9.1 K to 18.7 K (+105.87 %) |
Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 18,750 | 13,125 | 72,375 | |
Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.16 | 18,750 | 1,202,964 | 9,098 | 27.8 K to 9.1 K (-67.33 %) |
Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 18,750 | 13,125 | 27,848 | 9.1 K to 27.8 K (+206.09 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 32,588 | |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 91,125 | |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 57.73 | 200 | 11,546 | 9,098 | 9.3 K to 9.1 K (-2.15 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 56.90 | 400 | 22,760 | 9,298 | 9.7 K to 9.3 K (-4.12 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 55.83 | 1,054 | 58,845 | 9,698 | 10.8 K to 9.7 K (-9.80 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 55.16 | 3,527 | 194,549 | 10,752 | 14.3 K to 10.8 K (-24.70 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 53.95 | 700 | 37,765 | 14,279 | 15 K to 14.3 K (-4.67 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 52.49 | 264 | 13,857 | 14,979 | 15.2 K to 15 K (-1.73 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 15,243 | 14.6 K to 15.2 K (+4.42 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 14,598 | 9.1 K to 14.6 K (+60.45 %) |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | A | 63.87 | 24,800 | 1,583,976 | 24,800 | |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Grant | A | 0.00 | 6,900 | 0 | 9,098 | 2.2 K to 9.1 K (+313.92 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 33,233 | |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 96,625 | |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.97 | 1,145 | 74,391 | 2,198 | 3.3 K to 2.2 K (-34.25 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.27 | 2,400 | 154,248 | 3,343 | 5.7 K to 3.3 K (-41.79 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 62.76 | 2,600 | 163,176 | 5,743 | 8.3 K to 5.7 K (-31.16 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 33,878 | |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 102,125 | |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 79.78 | 445 | 35,502 | 2,198 | 2.6 K to 2.2 K (-16.84 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 78.71 | 2,237 | 176,074 | 2,643 | 4.9 K to 2.6 K (-45.84 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 78.02 | 2,463 | 192,163 | 4,880 | 7.3 K to 4.9 K (-33.54 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 76.53 | 1,000 | 76,530 | 7,343 | 8.3 K to 7.3 K (-11.99 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 34,523 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 107,625 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.25 | 84 | 5,397 | 2,198 | 2.3 K to 2.2 K (-3.68 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 63.60 | 1,600 | 101,760 | 2,282 | 3.9 K to 2.3 K (-41.22 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 62.62 | 2,800 | 175,336 | 3,882 | 6.7 K to 3.9 K (-41.90 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 61.79 | 1,300 | 80,327 | 6,682 | 8 K to 6.7 K (-16.29 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.08 | 361 | 21,689 | 7,982 | 8.3 K to 8 K (-4.33 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 35,168 | |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 113,125 | |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.66 | 3,181 | 205,683 | 2,198 | 5.4 K to 2.2 K (-59.14 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 63.98 | 2,964 | 189,637 | 5,379 | 8.3 K to 5.4 K (-35.53 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 35,813 | |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 118,625 | |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 61.65 | 1,150 | 70,898 | 999 | 2.1 K to 999 (-53.51 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.99 | 3,439 | 209,745 | 2,149 | 5.6 K to 2.1 K (-61.54 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.15 | 1,556 | 93,593 | 5,588 | 7.1 K to 5.6 K (-21.78 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 7,144 | 6.5 K to 7.1 K (+9.92 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 6,499 | 999 to 6.5 K (+550.55 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 13,542 | 230,214 | 36,458 | |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 8,625 | 6,038 | 124,125 | |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 72.92 | 4,925 | 359,131 | 999 | 5.9 K to 999 (-83.14 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 72.15 | 8,416 | 607,214 | 5,924 | 14.3 K to 5.9 K (-58.69 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 71.22 | 7,395 | 526,672 | 14,340 | 21.7 K to 14.3 K (-34.02 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 70.34 | 1,431 | 100,657 | 21,735 | 23.2 K to 21.7 K (-6.18 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 13,542 | 230,214 | 23,166 | 9.6 K to 23.2 K (+140.71 %) |
Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 8,625 | 6,038 | 9,624 | 999 to 9.6 K (+863.36 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 8,625 | 6,038 | 132,750 | |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 58.05 | 2,703 | 156,909 | 999 | 3.7 K to 999 (-73.01 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 56.93 | 3,345 | 190,431 | 3,702 | 7 K to 3.7 K (-47.47 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 55.94 | 2,577 | 144,157 | 7,047 | 9.6 K to 7 K (-26.78 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 8,625 | 6,038 | 9,624 | 999 to 9.6 K (+863.36 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 8,625 | 6,038 | 141,375 | |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 52.22 | 130 | 6,789 | 999 | 1.1 K to 999 (-11.51 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 51.59 | 1,674 | 86,362 | 1,129 | 2.8 K to 1.1 K (-59.72 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 50.42 | 2,330 | 117,479 | 2,803 | 5.1 K to 2.8 K (-45.39 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 49.45 | 4,491 | 222,080 | 5,133 | 9.6 K to 5.1 K (-46.66 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 8,625 | 6,038 | 9,624 | 999 to 9.6 K (+863.36 %) |
Jun 23 2014 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | A | 17.00 | 50,000 | 850,000 | 50,000 |
Page: 1